JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 27 No. 7 1207-1211
© 1986 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koral, K. F.
Right arrow Articles by Beierwaltes, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koral, K. F.
Right arrow Articles by Beierwaltes, W. H.

Iodine-131 Treatment of Thyroid Cancer: Absorbed Dose Calculated from Post-Therapy Scans

Kenneth F. Koral, Ronald S. Adler*, James E. Carey and William H. Beierwaltes

Division of Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, Michigan

Correspondence: For reprints contact: Kenneth F. Koral, PhD, Div. of Nuclear Medicine, University of Michigan, R3054 Kresge II, Ann Arbor, MI 48109.

ABSTRACT

The radiation absorbed dose for nine neck lesions distributed among four thyroid-cancer patients was measured directly from images taken after administration of a treatment dose of 131I. The tumor volume was measured with anterior plus lateral pinhole images by determining magnification and assuming an ellipsoidal shape. Uptake and effective half-life were determined from serial anterior images by use of a calibration curve. Dose lower limits ranged from 2,400 to 29,900 rad. Response to treatment was judged on the basis of one or more follow-up scans at least 8 mo later. All lesions responded to the therapy administration which ranged from 150 to 175 mCi.

FOOTNOTES

* Present address: Department of Radiology, University of Michigan Medical Center, Ann Arbor, MI.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
Aaron. P. Brown, J. Chen, Y. J. Hitchcock, A. Szabo, D. C. Shrieve, and Jonathan. D. Tward
The Risk of Second Primary Malignancies up to Three Decades after the Treatment of Differentiated Thyroid Cancer
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 504 - 515.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
S E M Clarke
Advances in radionuclide imaging: radionuclide imaging as a guide to therapy
Imaging, September 1, 2001; 13(3): 171 - 184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1986 by the Society of Nuclear Medicine.